Welcome to HDBuzzCast, the official podcast of HDBuzz! In this inaugural episode, Dr Ed Wild and Dr Jeff Carroll introduce HDBuzzCast and talk about the five new clinical trials enrolling now or starting soon for Huntington's disease. Plus, a detailed discussion of the eagerly-awaited clinical trial of the first 'huntingtin lowering' drug to be tested in Huntington's diease. Called HTT-Rx, the drug is an antisense oligonucleotide developed by Isis Pharmaceuticals Inc. If you have questions about any aspect of HD research, send them to [email protected].